TAIWAN BIO THERAPEUTICS INC. – Trademark Portfolio
Entity Type: 03
TAIWAN BIO THERAPEUTICS INC. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include TAIWAN BIO THERAPEUTICS. The owner is based in Zhubei City, Hsinchu County.
4F., No. 66, Shengyi 2nd Rd.,
Zhubei City, Hsinchu County 302 , TW
Showing of trademarks Trademarks
Trademark Classifications
TAIWAN BIO THERAPEUTICS INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does TAIWAN BIO THERAPEUTICS INC. have?
TAIWAN BIO THERAPEUTICS INC. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does TAIWAN BIO THERAPEUTICS INC. file in?
TAIWAN BIO THERAPEUTICS INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are TAIWAN BIO THERAPEUTICS INC.'s most well-known trademarks?
TAIWAN BIO THERAPEUTICS INC.'s registered trademark portfolio includes well-known marks such as TAIWAN BIO THERAPEUTICS. These are among 2 currently registered trademarks in the portfolio.
What is TAIWAN BIO THERAPEUTICS INC.'s trademark registration success rate?
TAIWAN BIO THERAPEUTICS INC. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.